We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/ TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these
Changes in concentrations of type IV collagen and tissue inhibitor of metalloproteinase-1 in patients with paraquat poisoning
✍ Scribed by Tsukasa Nakamura; Chifuyu Ushiyama; Noriaki Shimada; Kayo Hayashi; Isao Ebihara; Masataka Suzaki; Hikaru Koide
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 72 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0260-437X
- DOI
- 10.1002/jat.779
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Respiratory failure is one of the major causes of death in patients with paraquat poisoning. In paraquat‐poisoned lungs, abnormal extracellular matrix regulation occurs. The aim of the present study is to determine whether serum concentrations of type IV collagen and tissue inhibitor of metalloproteinase‐1 (TIMP‐1) are altered during the course of paraquat poisoning and whether haemoperfusion therapy affects these concentrations. Twenty‐one patients were admitted within 3 h after ingestion of paraquat and all patients received direct haemoperfusion therapy. Five out of 21 patients survived and 16 patients died within 28 days. Plasma paraquat concentrations in non‐survivors (5740 ± 380 µg l^−1^) were not significantly different from those in survivors ( 5920 ± 280 µg l^−1^) before treatment. Haemoperfusion reduced these concentrations in both non‐survivors (120 ± 7 µg l^−1^) as well as survivors (136 ± 9 µg l^−1^) on day 5. Serum concentrations of type IV collagen and TIMP‐1 in survivors showed little change between day 1 (type IV collagen, 90.4 ± 3.6 ng ml^−1^; TIMP‐1, 172.2 ± 7.0 ng ml^−1^) and day 5 (type IV collagen, 92.6 ± 4.2 ng ml^−1^; TIMP‐1, 174.2 ± 7.2 ng ml^−1^). In contrast, these concentrations in non‐survivors on day 5 (type IV collagen, 143.6 ± 7.8 mg ml^−1^; TIMP‐1, 246.8 ± 13.6 ng ml^−1^) were significantly higher than those on day 1 (type IV collagen, 88.4 ± 4.2 ng ml^−1^, P < 0.01; TIMP‐1, 170.6 ± 9.2 ng ml^−1^, P < 0.05). These data suggest that serum concentrations of type IV collagen and TIMP‐1 may be useful indicators for the development of respiratory failure in patients with paraquat poisoning. Copyright © 2001 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
To assess the clinical value of serum biochemical markers, the aminoterminal peptide of type III procollagen, type IV collagen 7S domain, the central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases, as a marker of hepatic fibrosis, we measured these four serum markers in
An increase of serum type IV collagen levels in patients with liver disease has been reported; however, the mechanisms of this increase are not yet well known. We recently developed an assay system for type IV collagen content in liver biopsy specimens. In this study, type IV collagen content in the
Studies from model systems suggest that matrix metalloproteinases (MMPs) are causally involved in tumor progression while tissue inhibitors of MMPs (TIMPs) prevent this progression. Here, we show that concentrations of TIMP-1 are significantly higher in breast carcinomas than in fibroadenomas. In pr
The pseudojoint cavity formed in patients undergoing total hip arthroplasty (THA) is later remodeled to synovial membrane-like tissue, which produces pseudosynovial fluid. This pseudosynovium also is an important source of matrix metalloproteinases (MMPs). As it is widely speculated that synovial fl